PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
21-Sep-2023 Launch of innovative Cardio-diabetes clinic in Lincolnshire improves outcomes for patients with diabetes following a heart attack Boehringer Ingelheim
21-Sep-2023 Interim results for the six months ended 30 June 2023 BenevolentAI
21-Sep-2023 Transgene advances its innovative immunotherapy pipeline and extends financial visibility until the end of 2024 Transgene
21-Sep-2023 argenx Announces VYVGART (efgartigimod alfa) Authorized for Sale by Health Canada for Generalized Myasthenia Gravis argenx
21-Sep-2023 Novo Nordisk and UNICEF to extend joint initiative to prevent global childhood obesity Novo Nordisk
21-Sep-2023 BeiGene Announces Positive Regulatory Updates in Europe and the U.S. After Recently Regaining Global Rights for TEVIMBRA® BeiGene
21-Sep-2023 BeiGene Strengthens Global Portfolio and Regains Full Rights from Novartis for Anti-PD-1 Antibody TEVIMBRA® (tislelizumab) BeiGene
21-Sep-2023 Pistoia Alliance Launches Lab of the Future Report, Finding AI is Set to be Top Technology Investment for Life Sciences Companies Over Next Two Years Pistoia Alliance
21-Sep-2023 Adtralza®▼(tralokinumab) is granted marketing authorisation from MHRA for a new pre-filled pen LEO Pharma
21-Sep-2023 CSL Seqirus Shares Data Demonstrating the Potential for Influenza Vaccination to Reduce the Burden on Healthcare Resources CSL Seqirus
21-Sep-2023 Immunomodulator I Patent Portfolio Strengthened Poolbeg Pharma plc
21-Sep-2023 Interim results for the six months ended 30 June 2023 Destiny Pharma plc
21-Sep-2023 BenevolentAI Signs Strategic Collaboration with Merck BenevolentAI
21-Sep-2023 Biotest AG: Biotest receives approval for innovative immunoglobulin Yimmugo® in the UK Biotest AG
21-Sep-2023 Xlife Sciences with significant progress in H1 2023 Xlife Sciences AG
21-Sep-2023 Lonza Confirms Details of Capital Markets Day and Reconfirms Outlook 2023 Lonza Group AG
19-Sep-2023 ABB and Porsche Consulting driving the future of analyzer manufacturing ABB
19-Sep-2023 3P Biopharmaceuticals continues its successful collaboration with Toleranzia AB to fight Myasthenia Gravis 3P Biopharmaceuticals
19-Sep-2023 Otsuka and Astex announce that the European Commission has approved INAQOVI® (oral decitabine and cedazuridine) for the treatment of adults with newly diagnosed acute myeloid leukaemia Otsuka Pharmaceutical Europe Ltd
19-Sep-2023 European Commission authorises ViiV Healthcare’s Apretude (cabotegravir long-acting and tablets) for HIV prevention ViiV Healthcare